| All (n = 110) | Private (n = 50) | NTP (n = 60) | P-value¥ | |||
---|---|---|---|---|---|---|---|
Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | ||
Pre-treatment | 1006 (1250) | 678 (430–1032) | 1308 (1652) | 868 (495–1247) | 753 (692) | 578 (430–849) | 0.010 |
Intensive phase | 860 (1228) | 471 (322–903) | 1166 (1591) | 763 (421–1161) | 606 (734) | 419 (258–692) | 0.003 |
Continuation phase | 776 (932) | 473 (292–882) | 969 (1178) | 602 (387–1008) | 615 (630) | 441 (252–774) | 0.070 |
End of treatment | 764 (887) | 602 (280–860) | 975 (1097) | 710 (366–1032) | 587 (621) | 464 (237–710) | 0.006 |